Finance entity

Dr. Heinz Schimmelbusch

Person

All 1 tracked stories fall under one category: markets. AMG Critical Materials N.V. is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 2 original sources on average. We currently track 1 Finance story that mention Dr. Heinz Schimmelbusch, all published on August 24, 2026.

Last mentioned: 1h ago

Entity pulse

Recent coverage · Dr. Heinz Schimmelbusch

1 story
5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Dr. Heinz Schimmelbusch

All 1 tracked stories fall under one category: markets. AMG Critical Materials N.V. is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 2 original sources on average. We currently track 1 Finance story that mention Dr. Heinz Schimmelbusch, all published on August 24, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 18 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Dr. Heinz Schimmelbusch. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. AMG announces Frankfurt secondary listing plan

    AMG Critical Materials N.V. says it will apply to list its shares on the Frankfurt Stock Exchange, with effectiveness expected in the course of 2026 and no new shares to be issued.

  2. Targeted effective date for Frankfurt listing

    AMG states the secondary listing is expected to become effective during 2026, complementing its primary Euronext Amsterdam listing.

Stories mentioning Dr. Heinz Schimmelbusch 1

Dr. Heinz Schimmelbusch is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.